5ml of tirzepatide MOUNJARO® Prefilled Pen (Tirzepatide)* Inj 10mg/.5ml Mounjaro (Tirzepatide) is administered as a subcutaneous injection once a week Tirzepatide 100mg

With low-calorie diets you can make 12 percent decreases in eight weeks, you could do that

The most common adverse events were gastrointestinal in nature, largely mild to moderate in severity and consistent with the GLP-1 receptor agonist (GLP-1RA) class

Confirm any handling question with the pharmacy that dispensed the pen

These are just the things that have worked for me over the past year and a half

Circ Res 119:11731176

Non-obese patients with metabolic syndrome, family history of type 2 diabetes, or documented cardiovascular disease often benefit from GLP-1 therapy as part of comprehensive risk reduction strategies